Phase 2 Colorectal Cancer Metastatic trials recruiting now

All Colorectal Cancer Metastatic trials, every phase

Other phases for Colorectal Cancer Metastatic

Phase 2 Colorectal Cancer Metastatic trials

• A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
  NCT06889610 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
  NCT07244705 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
  NCT05759728 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
  NCT07550088 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
  NCT06547203 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
  NCT07044921 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
  NCT06540326 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
  NCT05057052 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
  NCT07462650 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
  NCT06282445 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
  NCT06440902 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
  NCT05727163 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
  NCT06763029 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
  NCT06634875 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
  NCT06605430 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
  NCT06764680 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
  NCT06300463 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
  NCT07213570 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
  NCT06685276 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
  NCT06589830 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
  NCT05913674 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
  NCT06714357 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
  NCT07012954 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.